Want to know how we craft impactful new partnerships,
keep our clients ahead of emerging issues,
and advance their strategic goals?
Explore our downloadable one-pagers and background material on C&M International,
how we work, and the results we achieve for our clients.
CMI Background
CMI Company Overview
Background on C&M International – who we are, how we work, and our results.
CMI APEC
Our unique history, experience, and expertise in leveraging the Asia-Pacific Economic Cooperation (APEC) forum as the region's premier economic policymaking platform.
Global Health
CMI Global Health
Our portfolio of initiatives and outcomes on behalf of innovative biopharmaceutical and medical technology companies, industry associations, and public health organizations.
Global Health: A Look Ahead At Trends In Seven Key Areas
“Global Health: What’s Ahead” is a compilation of CMI's seven-part forecast series, exploring the important global health trends and challenges that businesses and governments may face this year.
Global Health: What’s Ahead for 2022: Vaccines
The development of consistent messaging on the value of vaccination across the life course remains a priority for all stakeholders.
Global Health: What’s Ahead for 2022: Health Financing
While public financing for healthcare remains essential, the private sector is using new, innovative financing techniques to complement public funding and close gaps in access.
Global Health: What’s Ahead for 2022: Antimicrobial Resistance
The search for lasting solutions to the broken AMR market is leading to actions such as paying for antibiotics based on their value to healthcare, rather than usage
Global Health: What’s Ahead for 2022: Digital Health/Artificial Intelligence (AI)
Advances in digital health innovation, including AI-enabled tools, allow public and private sector stakeholders to use this technology to improve healthcare delivery and outcomes and drive supportive policy efforts.
Global Health: What’s Ahead for 2022: Oncology
While the true toll of COVID-19-related disruptions in cancer care may only come to light in 2022 and beyond, awareness campaigns, advanced technology, and new planning efforts have the potential to mitigate the problems this disruption has caused.
Global Health: What’s Ahead for 2022: Rare Diseases
The outlook for fighting rare diseases is brightening as a result of scientific advances, rising global awareness, regulatory momentum, and attention from institutional payors.
Global Health: What’s Ahead for 2022: Women's Health
While COVID-19 had a negative impact on women’s health and well-being worldwide and stalled progress on a number of critical women’s health initiatives, global public health authorities are hopeful that several issues will come to the forefront in 2022.
Global Health
CMI Global Health
Our portfolio of initiatives and outcomes on behalf of innovative biopharmaceutical and medical technology companies, industry associations, and public health organizations.
Global Health: A Look Ahead At Trends In Seven Key Areas
“Global Health: What’s Ahead” is a compilation of CMI's seven-part forecast series, exploring the important global health trends and challenges that businesses and governments may face this year.
Global Trade & Investment
CMI Supply Chain & Trade Policy
Our unparalleled expertise in leveraging free trade agreements and trade policy to deliver supply chain efficiencies and costs savings.
